Trastuzumab en es it fr

Trastuzumab Brand names, Trastuzumab Analogs

Trastuzumab Brand Names Mixture

  • Filaribits Plus 180/136mg Chewable Tablet (Diethylcarbamazine citrate + Oxibendazole)

Trastuzumab Chemical_Formula

C6470H10012N1726O2013S42

Trastuzumab RX_link

http://www.rxlist.com/cgi/generic/trastuz.htm

Trastuzumab fda sheet

Trastuzumab FDA

Trastuzumab msds (material safety sheet)

Trastuzumab Synthesis Reference

No information avaliable

Trastuzumab Molecular Weight

145531.5

Trastuzumab Melting Point

61 oC (FAB fragment), 71 oC (whole mAb)-Vermeer, A.W.P. & Norde, W., Biophys. J. 78:394-404 (2000).

Trastuzumab H2O Solubility

No information avaliable

Trastuzumab State

Liquid

Trastuzumab LogP

-0.415

Trastuzumab Dosage Forms

Solution (IV Infusion)

Trastuzumab Indication

For treatment of HER2-positive metatsatic breast cancer

Trastuzumab Pharmacology

Used in the treatment of HER2-positive breast cancer. HER2 protein overexpression is observed in 25%-30% of primary breast cancers.Trastuzumab has been shown, in both in vitro assays and in animals, to inhibit the proliferation of human tumorcells that overexpress HER2. It is a mediator of antibody dependent cellular cytotoxicity, in that the binding of the antibody to HER2 overexpressing cells leads to preferential cell death.

Trastuzumab Absorption

No information avaliable

Trastuzumab side effects and Toxicity

No information avaliable

Trastuzumab Patient Information

No information avaliable

Trastuzumab Organisms Affected

Humans and other mammals